UBS Maintains a 'Buy' on Medtronic, Inc. (MDT); Probably Still Some Room to Work

Article Stock Quotes (1) Comments (0)

UBS maintains a 'Buy' on Medtronic, Inc. (NYSE: MDT) price target of $46.00 (from $45.00).

Analyst, Rajeev Jashnani, reviewing MDT's in-line results for Q1 ($0.85 and $4.01B and also reaffirming FY outlook), said there's probably still some room to work.

For an analyst ratings summary and ratings history on Medtronic, Inc. click here. For more ratings news on Medtronic, Inc. click here.

Shares of Medtronic, Inc. closed at $41.14 yesterday, with a 52 week range of $31.06-$41.79.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• UPDATE: UBS Downgrades Carnival (CCL) to Neutral; Worst May Not Be Behind
• UPDATE: Michael Kors (KORS) Under-Appreciated; Canaccord Genuity Starts at Buy
• Microsoft (MSFT) Rally Not Over Says UBS; Raises PT to $40

Create E-mail Alert Related Categories

Analyst Comments, Analyst EPS View

Related Entities

UBS

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?